Document is current
Any future updates will be listed below
-
Authors
Anders, Hans-Joachim https://orcid.org/0000-0003-2434-2956
Kitching, A. Richard https://orcid.org/0000-0002-2713-2391
Leung, Nelson https://orcid.org/0000-0002-5651-1411
Romagnani, Paola
- License Information
-
More Information
Article History
Accepted: 23 November 2022
First Online: 12 January 2023
Change Date: 6 November 2023
Change Type: Update
Change Details: In the version of the article initially published, affiliation 8 did not reflect a 2023 change in the institution’s name, which has now been updated.
Competing interests
: H.-J.A. has received consultancy or lecture fees from Boehringer, Bayer, GlaxoSmithKline, AstraZeneca, Novartis, Otsuka, Janssen, Kezar, Lilly and PreviPharma. A.R.K. has received lecture fees from Vifor Pharma and research funding via consultancy and grants from Vifor, Visterra, Toleranzia, Variant Bio and CSL Limited. N.L. has received research funding from Omeros. P.R. has nothing to disclose.
